FINNENCE ▪ THE WIRE FILE
THE WIRE · № 65735
News■ Unclear/unknown
IVD Quality Control Market to Reach US$ 2.2 Bn by 2031, Growing at 5.3% CAGR as Labs Shift to Automated QC Workflows: New Report by Wissen Research
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-05 18:01 UTC
LAST UPDATE2026-10-05 18:01 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
An IVD quality-control market forecast is a paid research report, not a traded-company disclosure.
Vendor research, treat with caution
CATALYST TO WATCH
None; no listed names cited
MAIN RISK
Forecast may be marketing-driven
FULL DISPATCH
SHERIDAN, Wyo., Oct. 5, 2026 /PRNewswire/ -- The global IVD quality control market is projected to grow from USD 1.7 billion in 2026 to USD 2.2 billion by 2031, registering a CAGR of 5.3% during the forecast period (2026–2031), according to a new study by Wissen Research. Growth is being...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma2026-10-05 18:54 UTC
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma2026-10-05 18:54 UTC
→CORRELATIONshares Healthcare
CPI | Invisalign Maker Must Face Renewed Antitrust Litigation2026-10-05 18:41 UTC
CPI | Invisalign Maker Must Face Renewed Antitrust Litigation2026-10-05 18:41 UTC
→CORRELATIONshares Healthcare
In test of investors' appetite, Lilly-connected TRex Bio plots $153 million IPO2026-10-05 19:31 UTC
In test of investors' appetite, Lilly-connected TRex Bio plots $153 million IPO2026-10-05 19:31 UTC
→CORRELATIONshares Healthcare
TRex shoots for $125M IPO to fund Treg-boosting therapies2026-10-05 20:33 UTC
TRex shoots for $125M IPO to fund Treg-boosting therapies2026-10-05 20:33 UTC
→CORRELATIONshares Healthcare
Trump is promising $90 Medicare rebate checks ahead of the midterms. Here’s the hidden cost.2026-10-05 20:39 UTC
Trump is promising $90 Medicare rebate checks ahead of the midterms. Here’s the hidden cost.2026-10-05 20:39 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.